Plasma lncRNA LIPCAR Expression Levels Associated with Neurological Impairment and Stroke Subtypes in Patients with Acute Cerebral Infarction: A Prospective Observational Study with a Control Group.
Zhong-Zhong LiuWen-Juan LinYue FengCong-Li HuangYin-Fang YanWei-Yan GuoHuan ZhangZhen LeiQing-Li LuPei LiuXue-Mei LinSong-di WuPublished in: Neurology and therapy (2023)
The expression level of lncRNA LIPCAR may play a potential role in the identification of neurological impairment and CE subtype in patients with ACI. Increased 1-year risk of adverse outcomes may be associated with high levels of LIPCAR expression.